NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board
Press Release – November 20, 2024 – BASEL, Switzerland – NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony Rosenberg as Chairman of the Board, bringing over 40 years of transformative leadership and industry expertise to the company. “Tony’s appointment marks an exciting new chapter for NUCLIDIUM. His exceptional experience and track record in the biotech and pharma industry will be invaluable as … Continue reading NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board